iX Biopharma
Sublinguale farmaceutische wafels en nutraceutische producten.
iX Biopharma produceert sublinguale farmaceutische wafels en nutraceutische producten vanuit haar activiteiten in Singapore. Het bedrijf levert gezondheidszorgsystemen, laboratoria, OEM-partners of gereguleerde exportklanten op zijn beursgenoteerde primaire markten.
- Type
- Manufacturer
- Location
- Singapore
- Founded
- 2008
- Website
- ixbiopharma.com
- Categories
- Medische en gezondheidszorgbenodigdheden, Supplementen & Welzijn
- Markets
- Singapore, Australië, Verenigde Staten, Verenigd Koninkrijk
Verified facts
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)